This article is for prescribers of Flovent Diskus and Flovent HFA
GlaxoSmithKline, the maker of Flovent®′ HFA and Flovent®′ Diskus inhalers, has notified the Food and Drug Administration (FDA) of their intent to discontinue manufacturing both these inhalers effective as of December 31, 2023.
This is a business decision made by GlaxoSmithKline and not related to any new safety or efficacy information.
We've reviewed our formulary coverage for the Flovent brand products and will be making some updates as of January 1, 2024.
Formulary | Covered alternative | Tier of covered alternative |
---|---|---|
Medicare Advantage | Arnuity Ellipta |
Tier 2 for 2-tier plans Tier 2 for 3-tier plans Tier 3 for 5-tier plans |
Blue Cross Blue Shield of Massachusetts | Fluticasone propionate |
Tier 2 for 3-tier plans Tier 3 for 4-tier plans Tier 2 for 5-tier plans Tier 3 for 6-tier plans |
*Note: Flovent Diskus and Flovent HFA are not currently covered on the Standard Control with Advanced Control Specialty Formulary.
Flovent HFA and Flovent Diskus will remain on most 2024 Federal Employee Program (FEP) drug formularies. Once supply is exhausted, members have the following options below:
FEP traditional
Medication |
Standard Option formulary tier |
Basic Option formulary tier |
FEP Blue Focus formulary tier |
---|---|---|---|
Flovent HFA | Tier 3 | Tier 3 | Not covered |
Fluticasone propionate HFA | Tier 1 | Tier 1 | Tier 1 |
Flovent Diskus | Tier 2 | Tier 2 | Tier 2 |
Arnuity Ellipta | Tier 2 | Tier 2 | Tier 2 |
FEP Medicare Prescription Drug Program (New for 2024)
New for 2024, this Medicare prescription drug benefit is for eligible members who qualify for Medicare Part A and/or Medicare Part B. Learn more at fepblue.org.
Medication | Standard Option | Basic Option | FEP Blue Focus |
---|---|---|---|
Flovent HFA | Tier 2 | Tier 2 | Not covered |
Fluticasone propionate HFA | Tier 2 | Tier 2 | Not covered |
Flovent Diskus | Tier 2 | Tier 2 | Not covered |
Arnuity Ellipta | Tier 2 | Tier 2 | Tier 2 |
MPC_071823-2K-19